Basilea announces Zevtera® (ceftobiprole) marketing authorization in Brazil
Basel/Allschwil, Switzerland, July 12, 2022 Basilea Pharmaceutica Ltd (SIX: BSLN), a commercial-stage biopharmaceutical company, announced…
Month: July 2022
Blockmed (BLMD) Is Now Available for Trading on LBank Exchange
Internet City, Dubai–(Newsfile Corp. – July 12, 2022) – LBank Exchange, a global digital asset…
Teijin and Fujitsu Agree to Jointly Develop Blockchain-based Commercial Platform to Promote Sustainable Use of Recycled Materials
TOKYO, Jul 12, 2022 – (JCN Newswire) – Teijin Limited (hereinafter Teijin) and Fujitsu Limited…
Canon Introduces RF 24mm f/1.8 Macro IS STM and RF 15-30mm f/4.5-6.3 IS STM Pair of Wide-Angle RF Lenses and More
Photography News: Canon expands their RF lens lineup with the RF 24mm f/1.8 Macro IS…
NEC Corporation strengthens its partnership with Project Management Institute (PMI) in Asia Pacific to drive business agility
TOKYO, Jul 12, 2022 – (JCN Newswire) – NEC Corporation, a leading global IT and…
AWS Selected as Delta’s Preferred Cloud Provider
Global airline uses AWS to deliver new digital travel services, streamline processes, enhance customer service,…
The Future of Pink is Green®: Barbie® Introduces New Dr. Jane Goodall and Eco-Leadership Team Certified CarbonNeutral® Dolls Made from Recycled Ocean-Bound Plastic
Latest Mattel sustainable product offering is in line with company goal to achieve 100% recycled,…
KBRA Releases Research — Litigation Finance ABS: Not Settling for Less
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research on the characteristics and key concepts related to litigation finance…
Rexlemestrocel-L to be Highlighted at Maxim’s Panel on Late-Stage Advancements in Heart Failure Therapeutics and Management
NEW YORK, July 11, 2022 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Annexon Closes $130 Million Private Placement Extending its Operating Runway into the Second Half of 2025
Proceeds Support Advancement of Broad Pipeline of Novel Complement Product Candidates for Diseases of the…
Danavation Technologies Announces Changes to the Board of Directors and Grant of Stock Options
Toronto, Ontario–(Newsfile Corp. – July 11, 2022) – Danavation Technologies Corp. (CSE: DVN) (OTCQB: DVNCF)…
StratCap Acquires Over $150 Million in Digital Infrastructure Assets
GREENWICH, Conn.–(BUSINESS WIRE)–StratCap (“StratCap” or “the Company”) is proud to announce that its wireless infrastructure…
Strategic Storage Trust VI, Inc. Acquires Storage Facility in the Jacksonville MSA
LADERA RANCH, Calif.–(BUSINESS WIRE)–Strategic Storage Trust VI, Inc. (“SST VI”), a publicly registered real estate…
Pact Group Unlocks Operational Efficiencies with SnapLogic’s Self-Service, No-Code Integration and Automation Flows
The Melbourne-based sustainable packaging leader leverages SnapLogic’s out-of-the-box, no-code platform to accelerate and scale automated…
Avicanna Announces Date of Upcoming Annual General and Special Meeting of Shareholders
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
Fulcrum Therapeutics Announces Departure of Chief Medical Officer
CAMBRIDGE, Mass., July 11, 2022 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage…
Neuronetics Announces Positive TMS Coverage Policies to Expand Patient Access to NeuroStar TMS Therapy for Mental Health
Proposed Medicare Coverage through First Coast and Novitas MACs Will Reduce Number of Medication Trials…
Soleno Therapeutics Announces Presentation of DCCR Data at the 11th International Prader-Willi Syndrome Organisation Conference
REDWOOD CITY, Calif., July 11, 2022 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO),…
Connect Moves Forward CBP-201 Top-Line Results Timeline for Pivotal China Atopic Dermatitis Trial to Second Half 2022
— Connect to Evaluate Efficacy and Safety Data on 255 Patients Already Enrolled — — Expected Timing…
TransCode Therapeutics Announces Expansion of Global RNA Oncology Patent Portfolio
BOSTON, July 11, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology…